Does mivamut interact with other medications? What issues should be paid attention to when using combined drugs?

Mifamurtide (Mifamurtide) is an immunomodulatory drug that is often used in combination with other drugs in the treatment of osteosarcoma. However, when used in combination, mivamutide may interact with some drugs, affecting the therapeutic effect or increasing the risk of adverse reactions. Therefore, patients need to pay special attention to drug interactions and communicate closely with their doctors when receiving mivamutide treatment to ensure the safety and effectiveness of the treatment.

Mivamutide is often used in combination with chemotherapy drugs , such as cisplatin, doxorubicin , etc. These chemotherapy drugs work by killing cancer cells directly, while mivamut helps fight tumors by activating the immune system. Therefore, the combination of mivamutide and chemotherapy drugs can enhance the anti-cancer effect in some cases. However, combined medication may lead to excessive activation of the immune system and aggravate side effects, especially triggering immune responses such as fever, chills, and muscle pain. Therefore, patient response needs to be closely monitored during combined use and drug dosage or frequency of administration should be adjusted if necessary.

Due to the immune-enhancing effects of mivamuttide, when used together with immunosuppressants , they may have mutually antagonistic effects. Immunosuppressants such as cyclosporine and tacrolimus are used to reduce the activity of the immune system and prevent rejection reactions. However, by activating the immune system, miavastatin may weaken the effect of immunosuppressants, leading to an excessive immune response . Therefore, if patients are taking immunosuppressants when receiving mivamutide treatment, they need to use it with caution and adjust the drug regimen under the guidance of a doctor.

The metabolism of mivamutin in the body involves the liver and kidneys. Therefore, when used in combination with drugs that affect liver and kidney function, the risk of liver and kidney damage may increase. For example, when used in combination with certain antibiotics or antifungal drugs , it may increase the burden on the liver and kidneys, leading to abnormal liver and kidney function. Therefore, when taking combined drugs, patients need to undergo regular liver and kidney function tests to ensure that the liver and kidney functions are within a safe range.

Although the main mechanism of action of mivamutin is through immune regulation, when used in combination with anticoagulant drugs (such as warfarin) or analgesics (such as nonsteroidal anti-inflammatory drugs), it may cause an increased risk of bleeding or gastrointestinal adverse reactions. Therefore, patients should inform their physician when using these medications so that appropriate monitoring and adjustments can be made.

xa0

References: https://pubmed.ncbi.nlm.nih.gov/23997016/